NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM4658826 Query DataSets for GSM4658826
Status Public on Dec 07, 2020
Title AB18_AB1_Day0_NR
Sample type SRA
 
Source name AB1 tumour
Organism Mus musculus
Characteristics tissue: AB1 tumour
age: 8-10 weeks
gender: f
treatment: aCTLA-4 + aPDL1
group: NR
strain: balb/c
timepoint: d0
Treatment protocol 100ug anti-CTLA-4 + anti-PDL1 given i.p., follwed by 100ug anti-PDL1 i.p. given 2 and 4 days later *Note some samples were collected before treatment
Growth protocol Subcutaneous tumour growth
Extracted molecule total RNA
Extraction protocol Frozen tumour dissociation with Trizol followed by chloroform extraction and purification using RNeasy MinElute
Illumina 50bp single-end sequencing
 
Library strategy RNA-Seq
Library source transcriptomic
Library selection cDNA
Instrument model Illumina HiSeq 2000
 
Description AB18
Data processing read alignment with Kallisto
count quantification with tximport
Genome_build: GRCm38.p6
Supplementary_files_format_and_content: txt files in compressed gz format
 
Submission date Jul 07, 2020
Last update date Dec 07, 2020
Contact name Wee Loong Chin
Organization name National Centre For Asbestos Related Diseases
Street address Level 5, Qq Block, Qeii Medical Centre 6 Verdun St, Nedlands
City Perth
ZIP/Postal code 6009
Country Australia
 
Platform ID GPL13112
Series (2)
GSE153941 Dynamic IFNβ signalling underlies treatment response to immune checkpoint therapy in cancer [bulk RNA-seq]
GSE153943 Dynamic IFNβ signalling underlies treatment response to immune checkpoint therapy in cancer
Relations
Alternative to GSM3291718
BioSample SAMN15464595
SRA SRX8679983

Supplementary data files not provided
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap